 | • レポートコード：MRC2303I0242 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界のウイルス標本採集市場規模が、予測期間中（2022年-2027年）に年平均14%で成長すると予測しています。本書では、ウイルス標本採集の世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（採血キット、ウイルス輸送培地、その他）分析、エンドユーザー別（病院＆診療所、診断検査室、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ、アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、その他）分析、競争状況、市場機会・将来の動向など、以下の構成でまとめております。また、Thermo Fisher Scientific、Puritan Medical Products、Trinity Biotech、Medical Wire and Equipment、Vircell、Quidel Corporation、Becton, Dickinson and Company 、Titan Biotech limited、COPAN diagnostics, Inc、EKF diagnostics、Hardy Diagnostics、Pretium Packagingなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のウイルス標本採集市場規模：製品種類別 - 採血キットの市場規模 - ウイルス輸送培地の市場規模 - その他製品種類の市場規模 ・世界のウイルス標本採集市場規模：エンドユーザー別 - 病院＆診療所における市場規模 - 診断検査室における市場規模 - その他エンドユーザーにおける市場規模 ・世界のウイルス標本採集市場規模：地域別 - 北米のウイルス標本採集市場規模 アメリカのウイルス標本採集市場規模 カナダのウイルス標本採集市場規模 メキシコのウイルス標本採集市場規模 … - ヨーロッパのウイルス標本採集市場規模 ドイツのウイルス標本採集市場規模 イギリスのウイルス標本採集市場規模 フランスのウイルス標本採集市場規模 … - アジア太平洋のウイルス標本採集市場規模 中国のウイルス標本採集市場規模 インドのウイルス標本採集市場規模 日本のウイルス標本採集市場規模 … - 中東・アフリカのウイルス標本採集市場規模 GCC諸国のウイルス標本採集市場規模 南アフリカのウイルス標本採集市場規模 … - 南米のウイルス標本採集市場規模 ブラジルのウイルス標本採集市場規模 アルゼンチンのウイルス標本採集市場規模 … - その他地域のウイルス標本採集市場規模 ・競争状況 ・市場機会・将来の動向 |
The virology specimen collection market is projected to grow at a CAGR of 14% during the forecast period (2022-2027).
COVID-19 had an unprecedented impact on the growth of the market, as with the spread of COVID-19 across the globe, accurate testing became important for containing the spread of the virus. The increase in the need to diagnose COVID-19-infected patients created lucrative opportunities for the virology specimen collection market. For instance, according to the World Health Organization (WHO) January 2022 update, the number of new COVID-19 cases increased by 5% across the globe from January 17th to January 23rd, 2022. Additionally, initiatives taken by the research institutes for the development of products also contributed to the growth of the market. For instance, in June 2020, the Indian Institute of Technology (IIT) Guwahati, in association with RR Animal Healthcare Ltd. and Guwahati Medical College and Hospital (GMCH), developed low-cost diagnostic kits. These include viral transport media kits, RT-PCR kits, and RNA isolation kits. Thus, such instances demonstrate that the impact of COVID-19 was positive on the growth of the market.
Moreover, the increasing prevalence of viral diseases and the emergence of new pathogens are expected to be the major driving factors for the market’s growth. According to the World Health Organization (WHO), in 2021, 60% of the global population was suffering from different infectious diseases. The rising incidence of viral diseases such as human immunodeficiency virus (HIV), influenza, Ebola, Zika virus, and other sexually transmitted diseases has led to an increase in demand for virology specimen collection for an effective diagnosis. According to the World Health Organization (WHO), January 2021 update, 38.4 million people were infected with the Human Immunodeficiency Virus (HIV). Similarly, the Food and Agriculture Organization (FAO) report published in January 2022 stated that 13 new cases of the avian influenza virus were reported in China, while 5 cases were reported in the United Kingdom. Therefore, the increasing prevalence of viral diseases and the emergence of new viral infections has led to an increase in demand for virology specimen collections owing to the effective diagnosis of viral infections and proper treatment, thereby propelling the market growth over the coming years.
Furthermore, the launch of products by the market players also contributed to the growth of the market. For instance, in June 2020, Becton, Dickinson, and Company received the CE mark in Europe for the “Vacutainer UltraTouch Push Button” blood collection set with a pre-attached holder. Such approvals and launches are expected to propel the growth of the market.
Thus, owing to the abovementioned factors, the market is expected to project significant growth over the forecast period. However, the high cost of collection kits and technologies may hinder the growth of the market.
Virology Specimen Collection Market Trends
The Hospitals and Clinics Segment is Expected to Hold a Major Market Share Over the Forecast Period
The hospitals and clinics segment is expected to register significant growth over the forecast period. This is attributed to an increase in the number of patients with respiratory virus infections and the growing need for treatment and diagnosis of viral diseases. The sudden outbreak of COVID-19 also boosted the demand for virology specimen collection due to the increased number of infectious cases of COVID-19 across the world.
Additionally, the World Health Organization (WHO) in 2021 reported that 3,481 cases of Ebola were diagnosed worldwide. In 2020, the WHO also stated that more than 1 million sexually transmitted infections were acquired per day worldwide. Also, it was estimated that there were 374 new infections with one of four sexually transmitted diseases. Such a high burden of viral diseases and infections creates the need for the effective treatment and diagnosis of disease in hospitals and clinics and, thus, is expected to drive the growth of the market segment over the forecast period.
Furthermore, the launch of products by the market players is also contributing to the growth of the market segment. For instance, in February 2020, Covaris, LLC released two new kits for viral RNA extraction from nasal or throat swab sample collection devices, namely the truXTRAC viral RNA extraction kit and the truXTRAC-PCR direct viral RNA extraction kit. Such launches will lead to greater commercial availability of the products across hospitals and clinics, in turn, boosting the segment’s growth.
Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period
North America is likely to dominate the global market owing to the technological innovations in the diagnostic and virology specimen collection devices used for disease testing. Increasing awareness regarding disease transmission and effective diagnosis of viral diseases accounted for the growth of this region’s virology specimen collection market.
The increasing funding activities from public and private organizations in the United States are also major factors contributing to the market’s growth. For instance, in July 2020, Hologic, Inc. received USD 7.6 million from the United States Department of Defense and the United States Department of Health and Human Services (HHS) to expand the production of specimen collection and processing consumables for SARS-CoV 2 testing.
Additionally, the launch of newer products is expected to propel the growth of the market in the region. For instance, in July 2022, Rhinostics introduced a breakthrough in automated sample collection technology with the launch of the VERIstic collection device focused on small volume blood collection in the United States. The VERIstic is ideal for use in at-home and clinician-assisted collection methods and is highly efficient, has a high-throughput replacement for antibody, hormone, and protein detection; sexually transmitted infections (STIs); dried blood spot (DBS) cards; genetic testing; clinical trials; and other applications enabled by simple finger prick collection. Such launches are propelling the growth of the market.
Furthermore, in January 2021, Microbix Biosystems Inc. reported the commercial availability of its viral transport medium (VTM) to support Canadian RT-PCR (molecular) testing for the virus-causing COVID-19 disease. This growing commercial availability of products is driving the growth of the market in the region.
Thus, owing to the abovementioned factors, the market is expected to show significant growth over the forecast period.
Virology Specimen Collection Market Competitor Analysis
The virology specimen collection market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Puritan Medical Products, Trinity Biotech, Medical Wire & Equipment, Vircell, Quidel Corporation, Becton, Dickinson and Company, Titan Biotech Limited, Copan Diagnostics, EKF Diagnostics, Hardy Diagnostics, Pretium Packaging, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Viral Diseases and Emergence of New Pathogens
4.2.2 Rising Number of Blood Donations
4.3 Market Restraints
4.3.1 High Cost of Collection Kits and Technologies
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Blood Collection Kits
5.1.2 Viral Transport Media
5.1.3 Others
5.2 By End users
5.2.1 Hospitals and Clinics
5.2.2 Diagnostic Laboratories
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific
6.1.2 Puritan Medical Products
6.1.3 Trinity Biotech
6.1.4 Medical Wire and Equipment
6.1.5 Vircell
6.1.6 Quidel Corporation
6.1.7 Becton, Dickinson and Company
6.1.8 Titan Biotech limited
6.1.9 COPAN diagnostics, Inc
6.1.10 EKF diagnostics
6.1.11 Hardy Diagnostics
6.1.12 Pretium Packaging
7 MARKET OPPORTUNITIES AND FUTURE TRENDS